Dirty-Appearing White Matter in Multiple Sclerosis: Volumetric MR Imaging and Magnetization Transfer Ratio Histogram Analysis

References

1. ↵
   Lassmann H. Neuropathology in multiple sclerosis: new concepts. Mult Scler 1998;4:93–98

   CrossRefPubMedWeb of Science
2. ↵
   van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000;26:2–10

   CrossRefPubMedWeb of Science
3. ↵
   Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3–24

   Abstract/FREE Full Text
4. ↵
   Isaac C, Li DK, Genton M, et al. Multiple sclerosis: a serial study using MRI in relapsing patients. Neurology 1988;38:1511–1515

   Abstract/FREE Full Text
5. ↵
   Kermode AG, Thompson AJ, Tofts P, et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis: pathogenetic and clinical implications. Brain 1990;113:1477–1489

   Abstract/FREE Full Text
6. ↵
   Barkhof F. Imaging of remyelination. Mult Scler 1997;3:129–132

   Abstract/FREE Full Text
7. ↵
   Li BS, Regal J, Soher BJ, et al. Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2003;24:68–74

   Abstract/FREE Full Text
8. ↵
   De Groot CJ, Bergers E, Kamphorst W, et al. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: increased yield of active demyelinating and (p)reactive lesions. Brain 2001;124:1635–1645

   Abstract/FREE Full Text
9. ↵
   Suzuki K, Kamoshita S, Eto Y, et al. Myelin in multiple sclerosis: composition of myelin from normal-appearing white matter. Arch Neurol 1973;28:293–297

   CrossRefPubMedWeb of Science
10. ↵
    Gass A, Barker GJ, Kidd D, et al. Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol 1994;36:62–67

    CrossRefPubMedWeb of Science
11. ↵
    Loevner LA, Grossman RI, Cohen JA, et al. Microscopic disease in normal-appearing white matter on conventional MR images in patients with multiple sclerosis: assessment with magnetization-transfer measurements. Radiology 1995;196:511–515

    PubMedWeb of Science
12. ↵
    Ciccarelli O, Werring DJ, Wheeler-Kingshott CA, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926–933

    Abstract/FREE Full Text
13. ↵
    Gawne-Cain ML, O’Riordan JI, Coles A, et al. MRI lesion volume measurement in multiple sclerosis and its correlation with disability: a comparison of fast fluid attenuated inversion recovery (fFLAIR) and spin echo sequences. J Neurol Neurosurg Psychiatry 1998;64:197–203

    Abstract/FREE Full Text
14. ↵
    Ropele S, Strasser-Fuchs S, Augustin M, et al. A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1885–1891

    Abstract/FREE Full Text
15. ↵
    Ge Y, Udupa JK, Nyul LG, et al. Numerical tissue characterization in MS via standardization of the MR image intensity scale. J Magn Reson Imaging 2000;12:715–721

    CrossRefPubMedWeb of Science
16. ↵
    Miki Y, Grossman RI, Udupa JK, et al. Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images-lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 1999;213:395–399

    CrossRefPubMedWeb of Science
17. Ge Y, Grossman RI, Udupa JK, et al. Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment. Neurology 2000;54:813–817

    Abstract/FREE Full Text
18. ↵
    Filippi M, Horsfield MA, Morrissey SP, et al. Quantitative brain MRI lesion load predicts the course of clinically isolated syndromes suggestive of multiple sclerosis. Neurology 1994;44:635–641

    Abstract/FREE Full Text
19. ↵
    Barbosa S, Blumhardt LD, Roberts N, et al. Magnetic resonance relaxation time mapping in multiple sclerosis: normal appearing white matter and the “invisible” lesion load. Magn Reson Imaging 1994;12:33–42

    CrossRefPubMedWeb of Science
20. ↵
    Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–1452

    Abstract/FREE Full Text
21. ↵
    Udupa JK, Odhner D, Samarasekera S. 3DVIEWNIX: an open, transportable, multidimensional, multimodality, multiparametric imaging software system. In: SPIE Proc;1994;58–73
22. ↵
    Udupa JK, Wei L, Samarasekera S, et al. Multiple sclerosis lesion quantification using fuzzy-connectedness principles. IEEE Trans Med Imaging 1997;16:598–609

    CrossRefPubMedWeb of Science
23. ↵
    Udupa JK, Nyul LG, Ge Y, Grossman RI. Multiprotocol MR image segmentation in multiple sclerosis: experience with over 1, 000 studies. Acad Radiol 2001;8:1116–1126

    CrossRefPubMedWeb of Science
24. ↵
    Woods R, Mazziotta J, Cherry S. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17:536–546

    CrossRefPubMedWeb of Science
25. ↵
    Siewert B, Patel MR, Mueller MF, et al. Brain lesions in patients with multiple sclerosis: detection with echo-planar imaging. Radiology 1995;196:765–771

    PubMedWeb of Science
26. ↵
    Ormerod IE, Johnson G, MacManus D, et al. Relaxation times of apparently normal cerebral white matter in multiple sclerosis. Acta Radiol Suppl 1986;369:382–384

    PubMed
27. ↵
    Armspach JP, Gounot D, Rumbach L, Chambron J. In vivo determination of multiexponential T2 relaxation in the brain of patients with multiple sclerosis. Magn Reson Imaging 1991;9:107–113

    CrossRefPubMedWeb of Science
28. ↵
    Grossman RI, Gonzalez-Scarano F, Atlas SW, et al. Multiple sclerosis: gadolinium enhancement in MR imaging. Radiology 1986;161:721–725

    PubMedWeb of Science
29. ↵
    McFarland HF, Frank JA, Albert PS, et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 1992;32:758–766

    CrossRefPubMedWeb of Science
30. ↵
    Miller DH, Rudge P, Johnson G, et al. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. Brain 1988;111:927–939

    Abstract/FREE Full Text
31. ↵
    Bruck W, Bitsch A, Kolenda H, et al. Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology. Ann Neurol 1997;42:783–793

    CrossRefPubMedWeb of Science
32. ↵
    Lai M, Hodgson T, Gawne-Cain M, et al. A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1996;60:339–341

    Abstract/FREE Full Text
33. ↵
    Guttmann CR, Ahn SS, Hsu L, et al. The evolution of multiple sclerosis lesions on serial MR. AJNR Am J Neuroradiol 1995;16:1481–1491

    Abstract
34. ↵
    Silver NC, Lai M, Symms MR, et al. Serial magnetization transfer imaging to characterize the early evolution of new MS lesions. Neurology 1998;51:758–764

    Abstract/FREE Full Text
35. Filippi M, Rocca MA, Martino G, et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998;43:809–814

    CrossRefPubMedWeb of Science
36. Pike GB, De Stefano N, Narayanan S, et al. Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology 2000;215:824–830

    PubMedWeb of Science
37. ↵
    Catalaa I, Grossman RI, Kolson DL, et al. Multiple sclerosis: magnetization transfer histogram analysis of segmented normal-appearing white matter. Radiology 2000;216:351–355

    PubMedWeb of Science
38. ↵
    Lassmann H. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis. Schriftenr Neurol 1983;25:1–135

    PubMed
39. ↵
    Lassmann H, Bruck W, Lucchinetti C, Rodriguez M. Remyelination in multiple sclerosis. Mult Scler 1997;3:133–136

    Abstract/FREE Full Text
40. ↵
    Dousset V, Grossman RI, Ramer KN, et al. Experimental allergic encephalomyelitis and multiple sclerosis: lesion characterization with magnetization transfer imaging. Radiology 1992;182:483–491

    PubMedWeb of Science
41. ↵
    Kimura H, Grossman RI, Lenkinski RE, Gonzalez-Scarano F. Proton MR spectroscopy and magnetization transfer ratio in multiple sclerosis: correlative findings of active versus irreversible plaque disease. AJNR Am J Neuroradiol 1996;17:1539–1547

    Abstract
42. ↵
    Pike GB, de Stefano N, Narayanan S, et al. Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR Am J Neuroradiol 1999;20:829–837

    Abstract/FREE Full Text
43. ↵
    Brochet B, Dousset V. Pathological correlates of magnetization transfer imaging abnormalities in animal models and humans with multiple sclerosis. Neurology 1999;53:S12–S17

    CrossRefPubMedWeb of Science
44. ↵
    van Buchem MA, Udupa JK, McGowan JC, et al. Global volumetric estimation of disease burden in multiple sclerosis based on magnetization transfer imaging. AJNR Am J Neuroradiol 1997;18:1287–1290

    Abstract
45. ↵
    Dousset V, Gayou A, Brochet B, Caille JM. Early structural changes in acute MS lesions assessed by serial magnetization transfer studies. Neurology 1998;51:1150–1155

    Abstract/FREE Full Text
46. ↵
    Deloire-Grassin MS, Brochet B, Quesson B, et al. In vivo evaluation of remyelination in rat brain by magnetization transfer imaging. J Neurol Sci 2000;178:10–16

    CrossRefPubMedWeb of Science
47. ↵
    Filippi M, Horsfield MA, Hajnal JV, et al. Quantitative assessment of magnetic resonance imaging lesion load in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998;64 Suppl 1:S88–S93

    PubMed
48. ↵
    Balcer LJ. Clinical outcome measures for research in multiple sclerosis. J Neuroophthalmol 2001;21:296–301

    PubMed